Literature DB >> 28319736

Structural variants in SNCA gene and the implication to synucleinopathies.

Ornit Chiba-Falek1.   

Abstract

Synucleinopathies are a group of neurodegenerative diseases that share a common pathological lesion of intracellular protein inclusions largely composed of aggregates of alpha-synuclein protein. Accumulating evidence, including genome-wide association studies, has implicated the alpha-synuclein (SNCA) gene in the etiology of synucleinopathies and it has been suggested that SNCA expression levels are critical for the development of these diseases. This review focuses on genetic variants from the class of structural variants (SVs), including multiplication of large genomic segments and short (<50bp) genomic variants such as simple sequence repeats (SSRs), within the SNCA locus. We provide evidence that SNCA-SVs play a key role in the pathogenesis of synucleinopathies via their effects on gene expression and on regulatory mechanisms including transcription and splicing.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28319736      PMCID: PMC5447477          DOI: 10.1016/j.gde.2017.01.014

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  73 in total

1.  Meta-analysis of alpha synuclein/ NACP polymorphism in Parkinson's disease in Japan.

Authors:  I Mizuta; M Nishimura; E Mizuta; S Yamasaki; M Ohta; S Kuno
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

2.  Genetic association between alpha-synuclein and idiopathic Parkinson's disease.

Authors:  Denise M Kay; Stewart A Factor; Ali Samii; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; John G Nutt; Jennifer S Montimurro; Robert G Keefe; April J Atkins; Dora Yearout; Cyrus P Zabetian; Haydeh Payami
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

3.  Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.

Authors:  O Chiba-Falek; R L Nussbaum
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

4.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Alexis Elbaz; Matthew J Farrer; John P Ioannidis; Rejko Krüger; Walter A Rocca; Nicole K Schneider; Timothy G Lesnick; Sarah J Lincoln; Mary M Hulihan; Jan O Aasly; Tetsuo Ashizawa; Marie-Christine Chartier-Harlin; Harvey Checkoway; Carlo Ferrarese; Georgios Hadjigeorgiou; Nobutaka Hattori; Hideshi Kawakami; Jean-Charles Lambert; Timothy Lynch; George D Mellick; Spiridon Papapetropoulos; Abbas Parsian; Aldo Quattrone; Olaf Riess; Eng-King Tan; Christine Van Broeckhoven
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

5.  Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.

Authors:  Ornit Chiba-Falek; Jeffrey A Kowalak; Mark E Smulson; Robert L Nussbaum
Journal:  Am J Hum Genet       Date:  2005-01-25       Impact factor: 11.025

6.  Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form.

Authors:  He-Jin Lee; Chan Choi; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

Review 7.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

8.  alpha-Synuclein and Parkinson disease susceptibility.

Authors:  S Winkler; J Hagenah; S Lincoln; M Heckman; K Haugarvoll; K Lohmann-Hedrich; V Kostic; M Farrer; C Klein
Journal:  Neurology       Date:  2007-09-13       Impact factor: 9.910

9.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Authors:  Nathan Pankratz; Jemma B Wilk; Jeanne C Latourelle; Anita L DeStefano; Cheryl Halter; Elizabeth W Pugh; Kimberly F Doheny; James F Gusella; William C Nichols; Tatiana Foroud; Richard H Myers
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

10.  Nonconsensus Protein Binding to Repetitive DNA Sequence Elements Significantly Affects Eukaryotic Genomes.

Authors:  Ariel Afek; Hila Cohen; Shiran Barber-Zucker; Raluca Gordân; David B Lukatsky
Journal:  PLoS Comput Biol       Date:  2015-08-18       Impact factor: 4.475

View more
  9 in total

1.  Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.

Authors:  Boris Kantor; Lidia Tagliafierro; Jeffrey Gu; Madison E Zamora; Ekaterina Ilich; Carole Grenier; Zhiqing Y Huang; Susan Murphy; Ornit Chiba-Falek
Journal:  Mol Ther       Date:  2018-08-29       Impact factor: 11.454

2.  Multiplication of the SNCA locus exacerbates neuronal nuclear aging.

Authors:  Lidia Tagliafierro; Madison Elena Zamora; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

3.  Differential Regional Responses in Soluble Monomeric Alpha Synuclein Abundance Following Traumatic Brain Injury.

Authors:  S W Carlson; H Q Yan; Y Li; J Henchir; X Ma; M S Young; M D Ikonomovic; C E Dixon
Journal:  Mol Neurobiol       Date:  2020-09-19       Impact factor: 5.590

Review 4.  Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.

Authors:  Dunhui Li; Craig Stewart McIntosh; Frank Louis Mastaglia; Steve Donald Wilton; May Thandar Aung-Htut
Journal:  Transl Neurodegener       Date:  2021-05-20       Impact factor: 8.014

Review 5.  Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease.

Authors:  Desiree A Piper; Danuta Sastre; Birgitt Schüle
Journal:  Front Neurosci       Date:  2018-04-09       Impact factor: 4.677

Review 6.  Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Authors:  Bradley Roberts; Frances Theunissen; Francis L Mastaglia; P Anthony Akkari; Loren L Flynn
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

7.  Bridging the gap: Short structural variants in the genetics of anorexia nervosa.

Authors:  Natasha Berthold; Julia Pytte; Cynthia M Bulik; Monika Tschochner; Sarah E Medland; Patrick Anthony Akkari
Journal:  Int J Eat Disord       Date:  2022-04-26       Impact factor: 5.791

8.  Lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury.

Authors:  Hong Zeng; Nan Liu; Yan-Yan Yang; Hua-Yi Xing; Xiao-Xie Liu; Fang Li; Gao-Yan La; Meng-Jie Huang; Mou-Wang Zhou
Journal:  J Neuroinflammation       Date:  2019-12-30       Impact factor: 8.322

Review 9.  Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules.

Authors:  Catherine M Cahill; Rozaleen Aleyadeh; Jin Gao; Changning Wang; Jack T Rogers
Journal:  Biomolecules       Date:  2020-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.